In addition, analysis of public data (GSE121634) [28, 29] demonstrated increased DKK1 expression in lung cancer cells resistant to another EGFR-TKI, erlotinib, in HCC827 and HCC4006 cells. This evidence concerns the gene EGFR and lung carcinoma.